ECJ
Court of Justice of the EU confirms zero or negative duration for SPCs
By Sidsel Hauge | Posted on December 13, 2011
On 8 December 2011, the Court of Justice of the European Union (CJEU) issued its judgment in case C-125/10 (“Merck”). This case concerns the duration of a Supplementary Protection Certificate (SPC) according to Article 13 of the SPC Regulation EG/469/2009. Summary of the case Merck applied for a SPC for the product Sitaglipin under conditions...
Filed under: Insights
Tags: CJ, ECJ, Patent, Pharmaceuticals, SPC
Recent contributors
Counsel, AU and NZ Patent Attorney
Senior Associate, China Patent Attorney
Associate, Attorney at Law
Counsel, European Patent Attorney
Partner, Attorney at Law, Business Area Manager
Partner, European Patent Attorney